Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer

Xiaojing Wang(Ruijin Hospital), Zhoujun Shen(Ruijin Hospital)
Oncotarget
August 7, 2017
Cited by 9


Related Papers